Similar companies
| Company | X Mentions | |
|---|---|---|
![]() |
Johnson & JohnsonJNJ |
113 34.7% |
![]() |
PfizerPFE |
264 196.6% |
![]() |
AstrazenecaAZN |
41 12.8% |
![]() |
AbbVieABBV |
84 86.7% |
![]() |
TherapeuticsMDTXMD |
6 500% |
Month over Month
Est. daily mentions of Cashtag on X.
| Dec 2025 | 92 | |
| Nov 2025 | 249 | |
| Oct 2025 | 160 | |
| Sep 2025 | 149 |
Analyzing X Mentions, how is Eli Lilly and Company performing compared to its industry peers?
Compared to its peers, Eli Lilly and Company ranks in the 55th percentile when it comes to X Mentions.
Why should an investor track X mentions?
Investors should track mentions of Eli Lilly and Company on X because sudden increases in activity often reflect shifts in retail interest, sentiment, or breaking news. These signals can precede sharp price movements, offering valuable context for timing trades or identifying emerging opportunities.
Sign up and get more insights on Eli Lilly and Company.
Sentiment on X
The sentiment score for Eli Lilly and Company on X is 57 (out of 100). This is considered neutral. Sentiment today is down compared to the 30 moving average.




